{
    "2020-12-29": [
        [
            {
                "time": "",
                "original_text": "医药行业2020年医保谈判事件点评：医保谈判结果公布 继续看好创新药和产业链",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "创新药",
                        "产业链"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "小摩减持泰格医药(03347)34.445万股，每股作价171.69港元 减持股份",
                "features": {
                    "keywords": [
                        "小摩",
                        "减持",
                        "泰格医药"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：海外疫情引关注 “国谈”下创新药企业面临新考验",
                "features": {
                    "keywords": [
                        "海外疫情",
                        "国谈",
                        "创新药企业"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：继续重点关注意创新核心竞争力和医药大消费两大投资方向",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新核心竞争力",
                        "医药大消费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "锚定“长坡厚雪”，A股渐趋赛道化",
                "features": {
                    "keywords": [
                        "长坡厚雪",
                        "A股",
                        "赛道化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}